Active Ingredient Retatrutide 12.5mg + Cagrilintide 2.5mg Strength Tier Research-grade only Time to Results Not applicable (research use) Sun Sensitivity Not applicable research peptide Regulatory Status Research use only not for human consumption Cycling / Off Period Per study protocol not for human cycling Best For For licensed researchers and laboratory professionals studying GLP-1, GIP, glucagon, and amylin receptor pathways
You should discuss the regulatory status, expected benefits, and risks with your provider before starting treatment
Abbreviation: -GGT -glutamyltransferase, AST Aspartate aminotransferase, ALT Alanine aminotransferase, FBP Fasting blood glucose, FINS Fasting insulin, HOMA-IR Homeostasis model assessment- Insulin Resistance, Hs-CRP Hypersensitivity C reaction protein, FFA free fatty acid, UA uric acid
Helps in the treatment of : Cardiovascular disease, bronchitis, diabetes, flu, inflammation, bowel diseases, osteoarthritis May enhance lung health
GMP l vit tt ca Good Manufacturing Practices c hiu l tiu chun thc hnh sn xut tt: L h thng quy nh chung hoc nhng hng dn m bo nh sn xut lun lm ra sn phm t cht lng ng k v an ton cho ngi s dng
